How to add additional study drugs on open label study cases after bookin
(Doc ID 1320583.1)
Last updated on JANUARY 30, 2022
Applies to:Oracle Argus Safety - Version 5.1.1 and later
Information in this document applies to any platform.
When the open label study case is booked in and if the user selects "0" products from the dialog box to be added, one product is added from the study configuration. How can a user add an additional study drug to the case?
To view full details, sign in with your My Oracle Support account.
Don't have a My Oracle Support account? Click to get started!
In this Document